Immediate Impact

2 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
2 intermediate papers

Works of Viola Baradari being referenced

Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma
2007
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer
2005

Author Peers

Author Last Decade Papers Cites
Viola Baradari 202 255 96 102 9 505
Chang-Hsien Lu 171 158 43 129 15 552
Shang-Tian Chuang 75 232 41 50 8 447
Maria Pia Staccioli 291 223 104 33 15 494
A Iveson 294 59 57 46 8 522
Hui-Lan Rao 104 259 71 99 13 471
Seok-Hyun Kim 185 247 57 60 17 445
Evelyn Loyer 279 145 52 47 11 475
Eunice Y. Lee 265 284 37 150 9 538
M W Büchler 215 209 34 49 9 453
Gerry Gin Wai Kwok 328 73 54 61 10 487

All Works

Loading papers...

Rankless by CCL
2026